Insider Buying: Opko Health CEO Purchases 31,700 Shares of Stock (OPK)
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost bought 31,700 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $8.72 per share, for a total transaction of $276,424.00. Following the completion of the purchase, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,331,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Opko Health (NYSE:OPK) traded down 0.03% on Tuesday, hitting $8.7176. 1,225,587 shares of the company’s stock traded hands. Opko Health has a 52-week low of $5.87 and a 52-week high of $12.95. The stock has a 50-day moving average of $9.26 and a 200-day moving average of $9.03. The company’s market cap is $3.557 billion.
A number of analysts have recently weighed in on OPK shares. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.
OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.